Olfactory receptor 2T11 Polyclonal Antibody, 100ul Biomatrix When bound to cyclophilin B

When bound to cyclophilin B

The antigen is being used as a target for immunotherapy treatment of human carcinomas

Mild chemoattractant for primary activated T-lymphocytes and a potent chemoattractant for chronically activated T-lymphocytes but has no chemoattractant activity for neutrophils| eosinophils| and resting T-lymphocytes

The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1

Olfactory receptor 2T11 Polyclonal Antibody, 100ul Biomatrix When bound to cyclophilin BOlfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G protein coupled receptors (GPCR) arising from single coding exon genes. Olfactory receptors share a 7 transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein mediated